BIOMAT Database Logo BIOMAT Database Logo

The chemotherapeutic agent bleomycin in a two-drug combination with zidovudine, ritonavir or indinavir synergistically inhibits HIV Type-1 replication in peripheral blood lymphocytes. 2001

N A Georgiou, and T van der Bruggen, and C A Jansen, and M Oudshoorn, and H S Nottet, and J J Marx, and B S van Asbeck
Department of Internal Medicine, Room F02.126, University Medical Center Utrecht, Utrecht, P.O. Box 85500, 3508 GA, Utrecht, The Netherlands.

It has been suggested that the combination of cancer chemotherapy with antiviral therapy is helpful for the containment of lymphomas in HIV-infected patients. Since we have recently shown that the nucleic acid binding chemotherapeutic agent bleomycin in itself has antiviral properties, we looked to see if there was any possible synergy with current anti-HIV agents. Combinations of zidovudine, indinavir or ritonavir with bleomycin, synergistically inhibited HIV-1(AT) replication in stimulated peripheral blood lymphocytes (combination index at 50% virus inhibition was 0.427, 0.604 and 0.535, respectively) and this synergism was not accompanied by any synergistic effects on cytotoxicity. We conclude from these data that further studies to investigate the clinical efficacy of combinations of antiviral and cancer chemotherapeutic agents are warranted in relation to viral load improvement.

UI MeSH Term Description Entries
D007963 Leukocytes, Mononuclear Mature LYMPHOCYTES and MONOCYTES transported by the blood to the body's extravascular space. They are morphologically distinguishable from mature granulocytic leukocytes by their large, non-lobed nuclei and lack of coarse, heavily stained cytoplasmic granules. Mononuclear Leukocyte,Mononuclear Leukocytes,PBMC Peripheral Blood Mononuclear Cells,Peripheral Blood Human Mononuclear Cells,Peripheral Blood Mononuclear Cell,Peripheral Blood Mononuclear Cells,Leukocyte, Mononuclear
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D001761 Bleomycin A complex of related glycopeptide antibiotics from Streptomyces verticillus consisting of bleomycin A2 and B2. It inhibits DNA metabolism and is used as an antineoplastic, especially for solid tumors. BLEO-cell,Blanoxan,Blenoxane,Bleolem,Bleomicina,Bleomycin A(2),Bleomycin A2,Bleomycin B(2),Bleomycin B2,Bleomycin Sulfate,Bleomycins,Bleomycinum Mack,Bléomycine Bellon,BLEO cell,BLEOcell,Bellon, Bléomycine,Mack, Bleomycinum,Sulfate, Bleomycin
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004338 Drug Combinations Single preparations containing two or more active agents, for the purpose of their concurrent administration as a fixed dose mixture. Drug Combination,Combination, Drug,Combinations, Drug
D004357 Drug Synergism The action of a drug in promoting or enhancing the effectiveness of another drug. Drug Potentiation,Drug Augmentation,Augmentation, Drug,Augmentations, Drug,Drug Augmentations,Drug Potentiations,Drug Synergisms,Potentiation, Drug,Potentiations, Drug,Synergism, Drug,Synergisms, Drug
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000903 Antibiotics, Antineoplastic Chemical substances, produced by microorganisms, inhibiting or preventing the proliferation of neoplasms. Antineoplastic Antibiotics,Cytotoxic Antibiotics,Antibiotics, Cytotoxic
D014779 Virus Replication The process of intracellular viral multiplication, consisting of the synthesis of PROTEINS; NUCLEIC ACIDS; and sometimes LIPIDS, and their assembly into a new infectious particle. Viral Replication,Replication, Viral,Replication, Virus,Replications, Viral,Replications, Virus,Viral Replications,Virus Replications

Related Publications

N A Georgiou, and T van der Bruggen, and C A Jansen, and M Oudshoorn, and H S Nottet, and J J Marx, and B S van Asbeck
Nevirapine synergistically inhibits HIV-1 replication in combination with zidovudine, interferon or CD4 immunoadhesin.
September 1993, AIDS (London, England),
N A Georgiou, and T van der Bruggen, and C A Jansen, and M Oudshoorn, and H S Nottet, and J J Marx, and B S van Asbeck
Chloroquine inhibits HIV-1 replication in human peripheral blood lymphocytes.
November 1998, Immunology letters,
N A Georgiou, and T van der Bruggen, and C A Jansen, and M Oudshoorn, and H S Nottet, and J J Marx, and B S van Asbeck
[Effective in HIV: dual combination with indinavir and ritonavir].
May 2001, Deutsche medizinische Wochenschrift (1946),
N A Georgiou, and T van der Bruggen, and C A Jansen, and M Oudshoorn, and H S Nottet, and J J Marx, and B S van Asbeck
Two-drug combinations of zidovudine, didanosine, and recombinant interferon-alpha A inhibit replication of zidovudine-resistant human immunodeficiency virus type 1 synergistically in vitro.
October 1991, The Journal of infectious diseases,
N A Georgiou, and T van der Bruggen, and C A Jansen, and M Oudshoorn, and H S Nottet, and J J Marx, and B S van Asbeck
Two drug combinations of zidovudine, didanosine, and recombinant interferon-alpha inhibit replication of zidovudine-resistant human immunodeficiency virus type 1 synergistically in vitro.
January 1991, Disease markers,
N A Georgiou, and T van der Bruggen, and C A Jansen, and M Oudshoorn, and H S Nottet, and J J Marx, and B S van Asbeck
Population pharmacokinetics of indinavir alone and in combination with ritonavir in HIV-1-infected patients.
September 2005, British journal of clinical pharmacology,
N A Georgiou, and T van der Bruggen, and C A Jansen, and M Oudshoorn, and H S Nottet, and J J Marx, and B S van Asbeck
Hair versus plasma concentrations as indicator of indinavir exposure in HIV-1-infected patients treated with indinavir/ritonavir combination.
January 2007, AIDS (London, England),
N A Georgiou, and T van der Bruggen, and C A Jansen, and M Oudshoorn, and H S Nottet, and J J Marx, and B S van Asbeck
Switch from ritonavir to indinavir in combination therapy for HIV-1-infected children.
April 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,
N A Georgiou, and T van der Bruggen, and C A Jansen, and M Oudshoorn, and H S Nottet, and J J Marx, and B S van Asbeck
9-Nitrocamptothecin inhibits HIV-1 replication in human peripheral blood lymphocytes: a potential alternative for HIV-infection/AIDS therapy.
July 2001, Journal of medical virology,
N A Georgiou, and T van der Bruggen, and C A Jansen, and M Oudshoorn, and H S Nottet, and J J Marx, and B S van Asbeck
Glycyrrhizin inhibits R5 HIV replication in peripheral blood monocytes treated with 1-methyladenosine.
January 2005, Pathobiology : journal of immunopathology, molecular and cellular biology,
Copied contents to your clipboard!